Commentary
The first decade of antiretroviral therapy in Africa
-
* Corresponding author: Nathan Ford nathan.ford@msf.org
1 Médecins Sans Frontières, Geneva, Switzerland
2 Centre for Infectious Disease Epidemiology and Research, University of Cape Town, South Africa
3 HIV/AIDS Unit, Infectious Disease Service, Geneva University Hospital, Switzerland
4 Faculty of Health Sciences, University of Ottawa, Canada
Globalization and Health 2011, 7:33 doi:10.1186/1744-8603-7-33
Published: 29 September 2011Abstract
The past decade has seen remarkable progress in increasing access to antiretroviral therapy in resource-limited settings. Early concerns about the cost and complexity of treatment were overcome thanks to the efforts of a global coalition of health providers, activists, academics, and people living with HIV/AIDS, who argued that every effort must be made to ensure access to essential care when millions of lives depended on it. The high cost of treatment was reduced through advocacy to promote access to generic drugs; care provision was simplified through a public health approach to treatment provision; the lack of human resources was overcome through task-shifting to support the provision of care by non-physicians; and access was expanded through the development of models of care that could work at the primary care level. The challenge for the next decade is to further increase access to treatment and support sustained care for those on treatment, while at the same time ensuring that the package of care is continuously improved such that all patients can benefit from the latest improvements in drug development, clinical science, and public health.